Drug-induced prolongation of the QTc interval is an important marker for potential proarrhythmic action. Prolongation of the QTc interval results from alteration of the ionic currents that regulate cardiac repolarisation. Such effects may result from direct drug action or alternatively they could also occur indirectly by drug-induced modulation of autonomic tone, which is known to regulate cardiac repolarization. This study examined the effects of physiological and drug-induced autonomic activation on heart rate, QT and QTc intervals.
Introduction
During the past decade the importance of careful assessment of all drugs for possible proarrhythmic effects has been recognized [1, 2] . Drugs that have the potential to alter cardiac myocyte ion channel activity resulting in delayed conduction or repolarization may carry a risk of inducing arrhythmias and assessment of all new compounds for such activity is essential in preclinical and clinical settings. Regulatory authorities have established guidelines to investigate the safety of new compounds and efforts are underway to develop international harmonization of these [3] . Preclinical studies include in vitro assessment of drug effects on HERG channel activity, Ikr current and action potential characteristics as well as in vivo studies to assess effects on the surface ECG. Clinical studies rely on the corrected QT interval (QTc) to assess repolarization and the QRS duration to assess ventricular conduction [4] . Prolongation of the QTc interval is recognized as an important marker of potential proarrhythmic risk.
Modulation of ventricular repolarization during alterations in heart rate is an essential mechanism to match cardiac contractile and electrophysiological function, but is only one of several mechanisms by which repolarization is regulated. Interventions that alter cardiac repolarization may involve several complex mechanisms. Thus, adrenergic stimulation is known to alter cardiac repolarization and this may involve direct stimulation of myocytes [5] , reduction in serum potassium [6] as well as heart rate-induced changes in repolarization. Furthermore, neural adrenergic stimulation is normally accompanied by a reduction in vagal tone, which may separately influence cardiac repolarization [7] . In addition, alterations in mechanical stretch associated with changes in end diastolic pressure or after-load may have effects on repolarization [8] . These factors are important to bear in mind when interpreting the significance of alterations in QTc intervals. In the case of interventions that result in changes in one of these physiological parameters, it may be impossible to ascertain whether changes in the QTc interval are the result of direct myocardial effects or indirect actions on one of these regulating mechanisms. Thus, a drug may alter the QTc interval by direct action on cardiac repolarization currents, or indirectly by affecting autonomic tone, cardiac loading or in some instances by a combination of mechanisms [9] . Direct and indirect drug effects on the heart is well illustrated by the action of vasodilators such as dyhidropyridine calcium antagonists, which may be negatively inotropic, but appear to be the reverse when studied in vivo due to reflex autonomic activation [10] .
These issues may be of particular importance in the context of drugs that appear to have no direct effect on cardiac repolarizing currents when studied in vitro at therapeutic concentration, yet appear to increase QTc intervals when studied in vivo . Drugs such as phosphodiesterase inhibitors appear to produce a modest increase in the QTc interval in man [11] but do not alter Ikr at therapeutic concentrations in vitro [11] . These compounds potentiate the effects of cyclic GMP resulting in vasodilation [12] , which in turn would be expected to cause autonomic activation [10] . We therefore hypothesized that reflex autonomic activation due to physiological interventions or vasodilation may contribute to changes in QTc intervals as observed in such studies. To test this we studied the effects of mental activation, postural change, exercise and glyceryl trinitrate (GTN) on QTc intervals in a group of healthy male subjects. Our results show that QTc interval is altered by such interventions, including a modest increase following sublingual GTN.
Materials and methods

Study population
Thirty male subjects, between the ages of 18 and 30, were recruited from the student and staff populations of Imperial College, London, after approval by the local research and ethics committee. All subjects gave informed, written consent. Volunteers were excluded if they suffered from any medical condition, took any regular medication, had any known allergy or hypersensitivity or had an abnormal ECG.
Study design
All subjects attended an introductory session before taking part in the study. During this session they had electrocardiograph (ECG) recordings taken and practised each the components of the study sessions until they were fully competent and comfortable with all procedures of the study. Subjects subsequently attended two identical study sessions and were randomly allocated, as individuals, into either group A ( n = 11) or group B ( n = 18). Subjects took 100 mg of atenolol, at 11.00 h, daily for four consecutive days, the last day being the morning of the first study session for those in group A and the second session for those in group B. Subjects were not blinded as to whether they were taking atenolol as it was expected that they would have been able to recognize the bradycardia effects of b blockade. The two sessions were separated by at least 10 days and all sessions commenced at 17.30 h. Prior to both sessions subjects had not consumed alcohol for 24 h. They had also not smoked cigarettes, taken caffeine, had a meal or undertaken strenuous exercise for 3 h.
Electrocardiography
Standard 12-lead ECG recordings were taken using a MAC 6 Marquette electrocardiogram (Marquette Electronics Inc., Milwaukee, WI, USA) at a paper speed of 50 mm s -1 and with a gain of 10 mm mV -1 . Limb lead positions were altered so as to reduce skeletal muscle artefact. The upper limb electrodes were attached to the skin overlying the lateral surface of the radial styloid process. The lower limb electrodes were attached to the skin overlying the medial surface of the body of the tibia. The skin was prepared by shaving, light abrasion and cleaning before attachment of the electrodes (QR-50-A; Medicotest, Crewe, UK). All recordings, with the exception of those during the Valsalva manoeuvre, were 12 s in length and included a 2.5-s trace of each lead as well as a continuous recording of lead II. The latter was used to make three QT interval measurements for each ECG using the first, middle and last complexes. A baseline resting ECG recording was taken before each component of the study and used for comparison.
Session protocol
The study protocol is illustrated in Figure 1 . Apart from the standing and exercise components, subjects were supine throughout. Each session began with a 30-min period resting in a low-stimulation environment. Five different mechanisms of altering autonomic tone were employed in the study. These were, in chronological order, a mental activation exercise, the Valsalva manoeuvre, postural change, physical exercise and administration of sublingual GTN. Mental activation was produced by a test, in which subjects were asked to complete as many multiplication and division questions as possible in 10 min and an ECG recording was obtained immediately following the test. After a further 20-min rest, three physiological manoeuvres were undertaken with a 5-min rest between each. (i) The Valsalva manoeuvre was carried out by forced expiration to maintain a pressure of 30 mmHg for 30 s. A continuous rhythm strip was recorded for the duration of the expiration and for the 30 s following. (ii) Postural change was studied by standing following a period of resting supine and recording an ECG after 3 min. (iii) Physical exercise involved running on the spot for 100 steps and an ECG was recorded when subjects were lying supine immediately after the exercise. After a further 45-min supine rest, subjects were given a 0.5-mg GTN tablet sublingually and remained supine for 3 min, when an ECG was recorded, corresponding to T max for sublingual GTN [13] . They were then asked to stand for 3 min when an ECG was recorded, after which they remained supine for the remainder of the study.
Measurement
QT intervals were measured by visual inspection from the onset of the Q wave, or R wave in the absence of a Q wave, to the end of the T wave, designated as the return to the isoelectric line (excluding U waves). Measurement of QT intervals was done using a digital calliper (Mitutoyo, Andover, UK). Calibration against known distances up to 15 mm gave a correlation coefficient of 1 and slope of 0.996. Two readers made all QT interval measurements and the same reader made all QT interval measurements for each subject to avoid interobserver bias. Readers were blinded to the study session. In addition, the calliper display was switched off during QT measurements; once the measurement was done the display was then turned on to take the reading. Reader training was carried out prior to the study and took the form of a seminar led by an experienced reader during which QT interval cut-off points were agreed. Sets of QT interval measurements carried out before and after training were used to assess interobserver variability, using standard methods [14] . The mean difference between readers following training was 0.2 ms [95% confidence interval (CI) -4.1, 3.8]. QTc intervals were calculated using the Fridericia formula QTc = QT/(R-R) 1/3 .
Statistics
The study was a nonblinded, randomized, crossover trial. The primary end point for the study was the change in QTc intervals at 3 min following sublingual GTN in supine subjects. Secondary end points were (i) the change in QTc intervals following physiological interventions and (ii) the effect of atenolol on induced QTc interval changes. All the data for all components of the study (mental arithmetic, standing, exercise, GTN and standing with GTN) were examined for period effect, treatment-period interaction and treatment effect (of atenolol) using standard methods [15] . Where a period effect was found the datasets from group A (atenolol before session 1) and group B (atenolol before session 2) were analysed separately and both sets of data presented. The significance of changes in heart rate, QT and QTc intervals from baseline following each component was examined by means of a paired t -test. A paired ttest was also employed to look for the difference between the changes in heart rate, QT and QTc following standing with and without GTN.
Results
Twenty-nine subjects completed the study. No serious adverse events were encountered during the study. One subject, from group B, was withdrawn from the study after a syncope during standing in session 1. No underlying cause of syncope was found on clinical, electrocardiographic or echocardiographic investigation. The ECG recordings during the Valsalva manoeuvre were judged to be of poor quality and no further analysis of the data was carried out. Electrocardiograph recordings were not taken if subjects had symptoms of dizziness ( n = 11) or syncope ( n = 2); these events occurred during standing with GTN, with atenolol ( n = 9), and without atenolol ( n = 4). Individual ECG recordings were discarded if the quality was poor (exercise: no atenolol n = 1; standing with GTN: no atenolol n = 1) or if there were flat T waves (standing: no atenolol n = 2; standing with GTN: no atenolol n = 1). Where data were discarded from one session the corresponding data from the other session were also discarded. No treatment period interaction was found in any of the datasets. No period effect (PE) was found in the primary end point (GTN); however, a PE was found when analysing the heart rate and QT interval data from the standing component ( P < 0.05 in both cases). This resulted from a tendency for the change in heart rate and QT interval on standing to be greater in session 2. There was also a PE in the QTc data from the exercise element ( P < 0.05) which resulted from a tendency for the decrease in QTc following exercise to be larger in session 1. In a component where a PE was found, the heart rate, QT and QTc data for group A and group B were analysed and illustrated separately. No attempt was made to correct for PE. Baseline values prior to each intervention are shown in Table 1 . Changes in heart rate, QT intervals and QTc intervals are illustrated in Figure 2 . Mental activity increased heart rate by 6 bpm ( P < 0.01) and decreased the QT interval by 14 ms ( P < 0.001) but resulted in no significant change in QTc intervals. Atenolol did not significantly effect the changes in heart rate and QT intervals. Standing increased heart rate by 26 bpm ( P < 0.001) in group A (atenolol before session 1) and 18 bpm ( P < 0.001) in group B (atenolol before session Table 1 Baseline values prior to each intervention 2). QT intervals were reduced by 55 ms in group A ( P < 0.001) and 46 ms in group B ( P < 0.001). QTc intervals were reduced by 20 ms in group A ( P < 0.001) and 17 ms in group B ( P < 0.001). Atenolol attenuated the increase in heart rate (group A, P < 0.01; group B, P < 0.01) and the decrease in QT interval in group A ( P < 0.01) but not in group B. Atenolol did not significantly alter the change in QTc interval.
Exercise increased heart rate by 50 bpm in group A ( P < 0.001) and 53 bpm in group B (P < 0.001). QT intervals were reduced by 85 ms in group A (P < 0.001) and 103 ms in group B (P < 0.001). QTc intervals were reduced by 23 ms in group A (P < 0.001) and by 34 ms in group B (P < 0.001). Atenolol attenuated the change in heart rate (group A, P < 0.05; group B, P < 0.001). In group B, atenolol also attenuated the change in QT interval (P < 0.001) but this was not found in group A. The change in QTc interval was attenuated by atenolol (group A, P < 0.05; group B, P < 0.001).
GTN increased supine heart rate by 6 bpm (P < 0.001), reduced QT intervals by 5 ms (P < 0.05) and increased QTc by 5.7 ms (95% CI 3.2; P < 0.01). Atenolol attenuated the change in heart rate (P < 0.001) and QT intervals (P < 0.001) but had no significant effect on the change in QTc.
Eighteen subjects completed both the standing and standing after GTN components. Standing, 3 min after GTN resulted in a substantial increase in heart rate and decrease in both QT and QTc intervals. The combined effect of GTN and standing was to increase heart rate by 44 bpm (P < 0.001). This change was attenuated by atenolol (P < 0.001) and was larger than the increase caused by standing alone (P < 0.001). GTN and standing decreased QT intervals by 68 ms (P < 0.001), which was larger than the change caused by standing alone (P < 0.01) and was attenuated by atenolol (P < 0.01). GTN and standing decreased QTc by 14 ms (P < 0.01). This was not significantly different from the change caused by standing alone. Atenolol had no significant effect on the change in QTc following GTN and standing.
Discussion
The main findings of the present study were that GTN in a widely used dose caused a small but significant increase in the QTc interval. This was accompanied by an increase in heart rate and reduction in QT interval. Standing and exercise reduced the QTc interval. b-Blockade attenuated the increase in heart rate and reduction in QT interval observed with standing, exercise and GTN. b-Blockade also attenuated the reduction in QTc interval seen with exercise, and appeared to blunt the effect of GTN on the QTc interval; however, a trend for increased QTc (3.3 ms; P = 0.06) remained. These findings suggest that changes in autonomic tone known to be associated with vasodilation and physiological manoeuvres effect QT intervals and that these effects persist despite correction for heart rate. The present find- 
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ings indicate that b-adrenergic activation contributed to QTc changes during exercise; however, atenolol did not significantly attenuate QTc changes with standing or GTN. This could reflect a greater role for reduced vagal tone (which was not blocked in this study) associated with autonomic activation [7] in the latter interventions, or alternatively incomplete sympathetic blockade.
Little is known about its effects on cardiac electrophysiology. In experimental studies the nitric oxide (NO) donor sodium nitroprusside had no effect on action potential duration [16] , as did blockade of NO formation with L-NAME [16] . Recent studies showed that GTN at a concentration of 1 mM had no effect on hERG channel activity or Ikr binding (D. Leishman, personal commuinication). A recent study suggests that NO may contribute to action potential shortening in endotoxic shock [17] . Thus, GTN appears to have no direct myocardial effects that would account for delayed repolarization and QTc prolongation. We suggest that the effect of GTN observed here is due to autonomic activation; however, further work is needed to confirm this and to establish whether changes in vagal tone contribute to this.
Adjustment of cardiac repolarization in relation to heart rate is an intrinsic property of cardiac muscle and is an essential mechanism to maintain appropriate systolic and diastolic intervals as heart rate changes. That cardiac repolarization is also regulated by extrinsic factors is also clear. Cardiac action potential duration is responsive to sympathetic and vagal tone [5, 7] . Thus, neuronal b-adrenergic stimulation may alter cardiac repolarization by direct action on cardiac tissue and indirectly by increasing heart rate. In clinical practice it is customary to express the QT interval corrected for heart rate and several formulae have been proposed for this purpose. However, it will be apparent that in circumstances where changes in repolarization are associated with changes in autonomic tone and other modulating influences as well as heart rate, simple heart rate correction would be unable to adjust for all of the factors operating. An alternative approach, based on careful observation of heart rate and QT intervals over prolonged periods, has been used to generate a composite mathematical description of the RR/QT relationship that includes all modulating influences [18] and thereby to provide a correction factor for all of these influences. The present study was designed to test whether a drug that has no direct action on cardiac repolarizing currents could alter QTc intervals as traditionally derived and consequently the Fridericia formula was used to correct the QT interval, as it provides good correction over modest range of heart rates as observed here. The results show that vasodilation and physiological manoeuvres known to cause reflex autonomic activation cause QTc interval changes despite heart rate correction.
The present findings indicate that drugs may alter the QTc interval indirectly by modifying repolarizing channels secondary to alterations in autonomic tone. GTN has been used in patients with acute myocardial infarction and at high risk of developing arrhythmias in conditions of intensive ECG monitoring for over three decades with no suggestion of proarrhythmia, and so the QTc prolongation observed here is highly unlikely to carry any adverse risk. In the present study the effects of standing and exercise were examined in order to assess effects on the QTc interval of common physiological manoeuvres that are known to alter autonomic tone and how these might interact with GTN. The greater heart increase seen with standing and exercise suggests a greater increase in autonomic tone than with GTN. Yet the former interventions reduced QTc intervals and in the case of exercise this was attenuated by b-blockade. Withdrawal of vagal tone may be a greater contributor to mild autonomic activation (and the lesser increases in heat rate) seen with standing, GTN and mental activation than with exercise, where sympathetic activation plays a greater role. This would be consistent with the substantial attenuation of the tachycardia and QTc changes by b-blockade in the latter. Further work is needed to clarify the relative contributions to vagal and sympathetic tone to QTc changes seen with modest autonomic activation.
Conclusions
GTN in a commonly used dose prolongs the QTc interval, an effect that is associated with autonomic activation and is blunted but not attenuated by b-blockade. We suggest that even in the absence of effects on the Ikr channel, drugs that alter autonomic tone may alter the QTc interval. Autonomic activation associated with standing and exercise increased heart rate and reduced the QTc interval and these are mediated at least in part by b-adrenergic activation. There are no reports of proarrhythmic effects of GTN despite its long-term use in high-risk patients under conditions of intensive ECG monitoring. Understanding the mechanism underlying drug-induced changes in QTc intervals may be important to assess the potential proarrhythmic risk, particularly if there is evidence of reflex autonomic activation.
Limitations of this study were that it was restricted to males in order to reduce variability in QTc intervals, and it did not include vagal or a-adrenergic blockade, lim-iting interpretation relating to possible parasympathetic or a-adrenergic contributions to the results observed.
We are grateful to Professor Nish Chaturvedi for statistical advice and to Pfizer for a research grant in support of the work.
